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An important problem in innovation management is financing research and 
development (R&D) activities due to the degree of uncertainty and risk associated with their 
outputs (Levitas and McFadyen, 2009). The initial public offering (IPO) is one of the most 
significant milestone in the life cycle of research-intensive and young startup firms (Shane 
and Stuart, 2002). Capital raised in the IPO can be used for pursuing extensive R&D projects 
and developing new capabilities to support growth and international expansion. 
New entrants and science-based firms are more likely to encounter finance difficulties 
than large established firms. Incumbent firms are assumed to enjoy experience, economies of 
scale and scope in both R&D and in marketing and a high level of appropriability of the 
returns from innovations (Gambardella, 1995; Sorescu, Chandy and Prabhu, 2003). Although 
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research-intensive firms preparing for an IPO often attract investors’ attention, this does not 
always result in investment because those firms have short operating histories, and have 
higher risk than larger and more established companies.  
There is little conclusive evidence as to how research-intensive entrepreneurial firms 
obtain informational advantages and how those advantages influence the economic value 
when they go public. Such companies are usually characterized by the lack of revenues for the 
foreseeable future. Thus, accounting data in many of these cases is simply too unreliable a 
measure.  
Gender diversity in top management teams (TMTs) is a useful non-financial signal to 
potential investors concerning the effectiveness of the TMT and the viability of the firm. 
Despite the extensive literature on IPOs, the research examining the impact of TMT 
gender diversity on IPO is very limited. Mohan and Chen (2004) carry out a study focused on 
gender effect on IPOs but they only include firms with women CEOs and do not consider the 
entire management team. To date, only two papers have addressed the relationship between 
gender diversity in executive management and the performance of IPO firms. They focus on 
large companies or study short periods of time. Krishnan and Parson (2007) investigate the 
impact of gender diversity in senior management on the stock returns after IPO using a 
sample of Fortune 500 companies. Welbourne, Cycyota and Ferrante (2007) examine the 
influence of the percentage of women on the TMT on the short- and long-term financial 
performance of companies that belong to different industries that went public in a given year. 
However, specific factors and indicators may provide valuable information to the market 
regarding organizational practices in each sector of activity.  
This study addresses how gender diversity in TMTs influences the success of the IPO of 
research-intensive firms, and how critical indicators of innovation capabilities for those types 
of firms can mediate the gender effect.  
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Our study found no support for the prediction that gender diversity in TMT positively 
influences IPO success. On the contrary, the results show a negative and significant effect of 
that type of demographic diversity. Nevertheless, relevant indicators to research-intensive 
firms, particularly those related to innovation capabilities, may reduce the potential gender 
stereotyping that influence their valuation.  
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